middle.news
Argent BioPharma Streamlines Operations and Secures German Approval Amid Funding Boost
6:50pm on Friday 31st of January, 2025 AEDT
•
Biotechnology
Read Story
Argent BioPharma Streamlines Operations and Secures German Approval Amid Funding Boost
6:50pm on Friday 31st of January, 2025 AEDT
Key Points
Closure of two manufacturing facilities to optimize resources
Delisting from London Stock Exchange effective December 31, 2024
Raised US$4.5 million via private placement with attached warrants
Received German BfArM approval for CogniCann distribution
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Argent Biopharma (ASX:RGT)
OPEN ARTICLE